Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNotes PayablesPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

CNBX Pharmaceuticals (CNBX) Shares Outstanding (2016 - 2025)

CNBX Pharmaceuticals (CNBX) has disclosed Shares Outstanding for 13 consecutive years, with $753.2 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Outstanding rose 2320.97% year-over-year to $753.2 million, compared with a TTM value of $753.2 million through Nov 2025, up 2320.97%, and an annual FY2025 reading of $554.0 million, up 1680.58% over the prior year.
  • Shares Outstanding was $753.2 million for Q4 2025 at CNBX Pharmaceuticals, up from $554.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $753.2 million in Q4 2025 and bottomed at $1.2 million in Q2 2021.
  • Average Shares Outstanding over 5 years is $95.7 million, with a median of $29.7 million recorded in 2023.
  • The sharpest move saw Shares Outstanding plummeted 99.21% in 2022, then surged 2320.97% in 2025.
  • Year by year, Shares Outstanding stood at $156.4 million in 2021, then tumbled by 99.21% to $1.2 million in 2022, then soared by 2185.65% to $28.3 million in 2023, then increased by 9.89% to $31.1 million in 2024, then soared by 2320.97% to $753.2 million in 2025.
  • Business Quant data shows Shares Outstanding for CNBX at $753.2 million in Q4 2025, $554.0 million in Q3 2025, and $92.5 million in Q2 2025.